Research ArticleClinical Studies
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA and FARKHAD MANAPOV
Anticancer Research April 2020, 40 (4) 2319-2322; DOI: https://doi.org/10.21873/anticanres.14198
MICHAEL HOFFMANN
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
DANIEL REITZ
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
JULIAN TAUGNER
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
OLARN ROENGVORAPHOJ
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
LUKAS KÄSMANN
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
CHUKWUKA EZE
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
MONIKA KARIN
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
CLAUS BELKA
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
FARKHAD MANAPOV
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
In this issue
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA, FARKHAD MANAPOV
Anticancer Research Apr 2020, 40 (4) 2319-2322; DOI: 10.21873/anticanres.14198
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA, FARKHAD MANAPOV
Anticancer Research Apr 2020, 40 (4) 2319-2322; DOI: 10.21873/anticanres.14198
Jump to section
Related Articles
Cited By...
- No citing articles found.







